SEOUL, Jan. 21 (Yonhap) -- South Korea's major pharmaceutical companies are poised to sharply expand their spending on research and development (R&D) in 2016, taking a page from Hanmi Pharmaceutical Co.'s aggressive investment that has led to a series
